# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023, Regulation 6: Amendment of regulation 29 in relation to England, Scotland and Wales (procedures for active implantable medical devices for clinical investigations)


After regulation 29(1), insert—
“(1A) A manufacturer or their UK responsible person may request a meeting with the Secretary of State in advance of giving notice in writing to the Secretary of State pursuant to paragraph (1) in order to—
(a) obtain advice on regulatory requirements relating to an intended clinical investigation; or
(b) obtain a statistical review in relation to an intended clinical investigation.”.

---
Source: https://www.legislation.gov.uk/uksi/2023/377/regulation/6 (the official version)
Page: https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

